Altshuler Shaham LTD Gilead Sciences, Inc. Transaction History

Altshuler Shaham LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $34,171 - $38,931	-442 Reduced 23.81%	1,414 $117,000
Q4 2022 May 09, 2023	BUY	$62.32 - $89.47 $7,540 - $10,825	121 Added 6.97%	1,856 $159,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $10,181 - $11,629	-171 Reduced 8.97%	1,735 $109,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $14,487 - $16,317	251 Added 15.17%	1,906 $118,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $56,124 - $70,330	969 Added 141.25%	1,655 $99,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $123,336 - $139,989	-1,901 Reduced 73.48%	686 $50,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $133,552 - $144,088	1,973 Added 321.34%	2,587 $182,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $33,258 - $36,339	-524 Reduced 46.05%	614 $42,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $68,280 - $77,907	1,138 New	1,138 $74,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $76,941 - $96,741	-1,239 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $88,688 - $102,984	1,226 Added 9430.77%	1,239 $96,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $554 - $610	9 Added 225.0%	13 $1,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $250 - $276	4 New	4 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.